Asia Pacific Blood Glucose Monitoring Market

Asia Pacific Blood Glucose Monitoring Market by Self-monitoring Blood Glucose Devices (Lancets, Test Strips, and Glucometer Devices), Continuous Glucose Monitoring Devices (Durables and Sensors), and Geography (India, China, South Korea, Japan, Australia, Vietnam, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia Pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3547
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 1
  • No. Of Pages: 165
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Asia Pacific blood glucose monitoring market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the growing diabetic population and increasing penetration of glucose monitoring systems.


Asia Pacific Blood Glucose Monitoring Market Key Takeaways

Blood glucose monitoring comprises the use of a glucose meter for testing the concentration of glycemia in the blood. A blood glucose test is typically performed by piercing the finger tip to draw blood and applying it to a chemically active disposable called as test-strip. Different technologies are used by the manufacturers to detect the blood sugar level, but the most widely adopted technology includes systems that measure an electrical characteristic to determine the glucose level in the blood. The test is usually referred to as capillary blood glucose (CBG) test. Healthcare professionals advise patients with diabetes mellitus on the appropriate monitoring of blood glucose level on regular basis. Blood glucose monitoring is done to track the patterns of blood glucose changes and assist in the planning of meals, activities, & required medications for the patients. Additionally, the regular testing regimen allows taking quick actions in case of hyperglycemia or hypoglycemia. The cost of using blood glucose meters is highly cost-benefit relative to the avoided medical costs of the complications of diabetes. Therefore, the blood glucose monitoring devices are widely used by the diabetic patient owing to its affordability and easy operation.

The COVID-19 pandemic has significantly changed the dynamics of healthcare industry. The high risk of developing serious illness due to coronavirus disease has made it challenging for several other healthcare problems including diabetes. Additionally, the pandemic situation has witnessed nationwide lockdowns and stringent regulations. Therefore, the outbreak overwhelmed home healthcare agencies with patients due to limited access to medical services. The consequent large scale manufacturing of home care devices for the patients having diabetes and other serious disorders had fuel the expansion of the market during the pandemic situations. This resulted into many opportunities for the expansion of blood glucose monitoring market.

Market Trends, Drivers, Restraints and Opportunities

  • Rising cases of diabetes & pre-diabetes and growing demand for advanced diabetes monitoring devices are the major factor propelling the market expansion during the projected period.
  • Increasing manufacturing of self-monitoring blood glucose devices is estimated to contribute to the market expansion during the forecast period.
  • Growing availability of healthcare reimbursements and rising adoption of new medical technologies are some of the factors expected to positively influence the market growth in the coming years.
  • Presence of a large proportion of undiagnosed diabetes patients is anticipated to hamper the market growth during the forecast period.
  • Increasing government initiatives to combat diabetes and rising corporative investments to streamline research & development activities in diabetes is expected to create numerous opportunities for the market growth in the coming years.

Scope of the Report

The report on the Asia Pacific blood glucose monitoring market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Blood Glucose Monitoring Market - Asia Pacific Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Self-monitoring Blood Glucose Devices (Lancets, Test Strips, and Glucometer Devices) and Continuous Glucose Monitoring Devices (Durables and Sensors)

Geographical Scope

India, China, South Korea, Japan, Australia, Vietnam, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Abbott Diabetes Care; Roche; Johnson & Johnson; Dexcom; and Medtronics

Asia Pacific Blood Glucose Monitoring Market Segment Insights

Glucometer devices segment is expected to grow at a rapid pace

Based on self-monitoring blood glucose devices, the market is segregated into lancets, test strips, and glucometer devices. The glucometer devices segment is expected to grow at a rapid pace during the projected period due to its economic affordability and easy usage. Moreover, the ease in handling glucometers and growing demand are expected to propel the growth of the market segment in the coming years. On the other hand, the test strips segment is anticipated to exhibit a substantial growth during the forecast period owing to the sedentary lifestyle and consequent increasing demand for blood glucose test strips from type-2 diabetic patients.


Asia Pacific Blood Glucose Monitoring Market By Self-monitoring Blood Glucose Devices

Sensors segment is projected to expand at a robust CAGR

On the basis of continuous glucose monitoring devices, the market is segmented into durables and sensors. The sensors segment is projected to expand at a robust CAGR during the forecast period owing to the elimination of the pain associated with finger picking. Furthermore, increasing replacement of invasive monitoring devices with the sensors that enable patients with self-monitoring is expected to encourage the growth of the market segment. However, the durables segment is anticipated to hold a significant market share during the forecast period due to the growing demand owing to accurate glucose level detection. Moreover, the growing economic development and changing consumer behavior are the factors anticipated to fuel the growth of market segment during the projected period.

China market anticipated to constitute a key market share

In terms of geography, the Asia Pacific lactic acid market is classified as India, China, South Korea, Japan, Australia, Vietnam, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia Pacific. The market in China is anticipated to constitute a key share of the market during the projected period owing to the increasing prevalence of metabolic illness and rising number of pre-diabetic patients in the country. Moreover, the region is expected to continue its dominance in the market due to the increasing technological transformation, rising number of insulin-requiring & insulin-dependent diabetes patients. On the other hand, the market in Japan is anticipated to exhibit a robust CAGR during the forecast period due to growing demand for advanced monitoring devices and rising trend of self-monitoring to cut down the expenditure on regular hospital visits.

Segments

Segments Covered in the Report
The Asia Pacific blood glucose monitoring market has been segmented on the basis of

Self-monitoring Blood Glucose Devices
  • Lancets
  • Test Strips
  • Glucometer Devices
Continuous Glucose Monitoring Devices
  • Durables
  • Sensors
Geography
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Vietnam
  • Malaysia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of Asia Pacific
Key Players
  • Abbott Diabetes Care
  • Roche
  • Johnson & Johnson
  • Dexcom
  • Medtronics

Competitive Landscape

Key players competing in the Asia Pacific blood glucose monitoring market are Abbott Diabetes Care; Roche; Johnson & Johnson; Dexcom; and Medtronics. Companies are focusing on market strategies and collaborating with other industry players for creating new security measures and technological advancements to expand their market share.

In November 2021, Medtronics planned to set up a global research & development center involving an investment of around USD 159 million at Hyderabad, India. The initiative facilitated the research work for medical products to treat over 70 health conditions that include surgical tools, insulin pumps, patient monitoring systems, and others.

In June 2020, Abbott Diabetes Care and Tandem Diabetes Care announced to finalize an agreement for developing integrated diabetes solutions at commercial level. The contract combined Abbott's world-leading1 continuous glucose monitoring (CGM) technology with Tandem's innovative insulin delivery systems. The joint acquisition aimed to provide multiple options for people to manage their diabetes, develop integration of technical devices, and associated commercial support activities.

Asia Pacific Blood Glucose Monitoring Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Glucose Monitoring Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Blood Glucose Monitoring Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Blood Glucose Monitoring Market - Supply Chain
  4.5. Global Blood Glucose Monitoring Market Forecast
     4.5.1. Blood Glucose Monitoring Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Blood Glucose Monitoring Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Blood Glucose Monitoring Market Absolute $ Opportunity
5. Global Blood Glucose Monitoring Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Blood Glucose Monitoring Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Blood Glucose Monitoring Demand Share Forecast, 2019-2026
6. North America Blood Glucose Monitoring Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Blood Glucose Monitoring Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Blood Glucose Monitoring Demand Share Forecast, 2019-2026
7. Latin America Blood Glucose Monitoring Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Blood Glucose Monitoring Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Blood Glucose Monitoring Demand Share Forecast, 2019-2026
8. Europe Blood Glucose Monitoring Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Blood Glucose Monitoring Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Blood Glucose Monitoring Demand Share Forecast, 2019-2026
9. Asia Pacific Blood Glucose Monitoring Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Blood Glucose Monitoring Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Blood Glucose Monitoring Demand Share Forecast, 2019-2026
10. Middle East & Africa Blood Glucose Monitoring Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Blood Glucose Monitoring Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Blood Glucose Monitoring Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Blood Glucose Monitoring Market: Market Share Analysis
  11.2. Blood Glucose Monitoring Distributors and Customers
  11.3. Blood Glucose Monitoring Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Abbott Diabetes Care Roche Johnson & Johnson Dexcom Medtronics
Segments Covered in the Report
The Asia Pacific blood glucose monitoring market has been segmented on the basis of

Self-monitoring Blood Glucose Devices
  • Lancets
  • Test Strips
  • Glucometer Devices
Continuous Glucose Monitoring Devices
  • Durables
  • Sensors
Geography
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Vietnam
  • Malaysia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of Asia Pacific
Key Players
  • Abbott Diabetes Care
  • Roche
  • Johnson & Johnson
  • Dexcom
  • Medtronics

Key players competing in the Asia Pacific blood glucose monitoring market are Abbott Diabetes Care; Roche; Johnson & Johnson; Dexcom; and Medtronics. Companies are focusing on market strategies and collaborating with other industry players for creating new security measures and technological advancements to expand their market share.

In November 2021, Medtronics planned to set up a global research & development center involving an investment of around USD 159 million at Hyderabad, India. The initiative facilitated the research work for medical products to treat over 70 health conditions that include surgical tools, insulin pumps, patient monitoring systems, and others.

In June 2020, Abbott Diabetes Care and Tandem Diabetes Care announced to finalize an agreement for developing integrated diabetes solutions at commercial level. The contract combined Abbott's world-leading1 continuous glucose monitoring (CGM) technology with Tandem's innovative insulin delivery systems. The joint acquisition aimed to provide multiple options for people to manage their diabetes, develop integration of technical devices, and associated commercial support activities.

Asia Pacific Blood Glucose Monitoring Market By Key Players

Buy Report